BlackRock’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
BlackRock's RXST Position: Q2 2026 in Review
BlackRock increased its RxSight (RXST) stake by 82% in Q2 2026, buying an estimated $15.7M and bringing the position to 5,790,408 shares worth $27.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3047.
BlackRock first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $144M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- BlackRock held 5,790,408 shares of RxSight worth $27.9M as of Q2 2026.
- BlackRock bought 2,603,316 RxSight shares in Q2 2026, an estimated $15.7M.
- RxSight made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3047 holding.
- BlackRock first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
- BlackRock's RxSight position peaked at $144M in Q2 2024.
- 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.